RME Stock Overview
Develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
No risks detected for RME from our risk checks.
ResMed Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$232.00 |
| 52 Week High | US$238.50 |
| 52 Week Low | US$138.00 |
| Beta | 0.69 |
| 11 Month Change | -2.73% |
| 3 Month Change | 14.74% |
| 1 Year Change | 66.49% |
| 33 Year Change | 2.56% |
| 5 Year Change | 70.59% |
| Change since IPO | 14,183.82% |
Recent News & Updates
Recent updates
Shareholder Returns
| RME | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 5.8% | -1.0% | -0.02% |
| 1Y | 66.5% | -7.3% | 8.2% |
Return vs Industry: RME exceeded the German Medical Equipment industry which returned -7.3% over the past year.
Return vs Market: RME exceeded the German Market which returned 8.2% over the past year.
Price Volatility
| RME volatility | |
|---|---|
| RME Average Weekly Movement | 4.1% |
| Medical Equipment Industry Average Movement | 5.4% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.3% |
Stable Share Price: RME has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: RME's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | 9,980 | Mick Farrell | www.resmed.com |
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights.
ResMed Inc. Fundamentals Summary
| RME fundamental statistics | |
|---|---|
| Market cap | €34.35b |
| Earnings (TTM) | €1.07b |
| Revenue (TTM) | €4.62b |
32.1x
P/E Ratio7.4x
P/S RatioIs RME overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RME income statement (TTM) | |
|---|---|
| Revenue | US$4.81b |
| Cost of Revenue | US$2.00b |
| Gross Profit | US$2.80b |
| Other Expenses | US$1.69b |
| Earnings | US$1.11b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 7.58 |
| Gross Margin | 58.33% |
| Net Profit Margin | 23.15% |
| Debt/Equity Ratio | 13.0% |
How did RME perform over the long term?
See historical performance and comparisonDividends
0.9%
Current Dividend Yield26%
Payout RatioDoes RME pay a reliable dividends?
See RME dividend history and benchmarks| ResMed dividend dates | |
|---|---|
| Ex Dividend Date | Nov 07 2024 |
| Dividend Pay Date | Dec 12 2024 |
| Days until Ex dividend | 18 days |
| Days until Dividend pay date | 17 days |
Does RME pay a reliable dividends?
See RME dividend history and benchmarks